XLV
State Street Health Care Select (ETF)
—
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
$167.26
+$3.86 (+2.36%)
Sign in to add XLV to a watchlist or set price alerts.
Price History
52-Week Range
Fundamentals
| Market Cap | - |
| P/E Ratio (TTM) | - |
| Forward P/E | - |
| EPS (TTM) | - |
| Dividend Yield | - |
| Profit Margin | - |
| Revenue Growth | - |
| ROE | - |
| Debt/Equity | - |
| Recommendation | - |
| Analyst Target | - |
| Analysts | - |
| Indexes | ETF |
Technical Indicators
| RSI (14) | 61.9 |
| Beta | - |
| SMA 20 | $161.41 |
| SMA 40 | $157.03 |
| 52-Week High | $168.53 |
| 52-Week Low | $127.96 |
| 50-Day Avg | $154.83 |
| 200-Day Avg | $152.00 |
| Avg Volume | $10.45M |
| Volume | $12.74M |
Performance Analysis
NEUTRALXLV presents a mixed picture with both positive and negative indicators.
-
Trading near its 52-week high ($168.53), which may indicate limited upside.
+
RSI at 61.9 shows positive momentum.
+
Price is above both the 50-day and 200-day moving averages — strong uptrend.
Recent News
Loading news...
Last updated: Jul 28, 2026 21:01 UTC
Back to Screener Export Report